Genomatix Microarray Analysis Pipeline achieves Affymetrix GeneChip compatible?status
Genomatix Software GmbH today announced that it has achieved GeneChip-compatible GeneChip® microarray platform and that it has joined Affymetrix GeneChip-compatible Applications Program, which provides customers with a broad spectrum of software solutions for biomedical research and development. As a GeneChip-compatible...Warts vaccine -- 1 of many in pipeline
A clinical trial treating the papillomaviruses responsible for genital warts was on target at the halfway mark, according to Australian of the Year 2006 Professor Ian Frazer and trial manager, sexual health specialist Dr David Jardine "The new treatmen...Third Wave to seek FDA clearences after expanding pipeline
The company said revenue in 2005 would probably be driven primari...$30 M Aid in the pipeline by WB for bird flu in Turkey
Taking into consideration the epidemic that is bird flu which is taking the world by storm WB might grant $30 M in aid to Turkey.// This follows a high level and numerous evaluations by the World Bank. But all this bore fruit and according to latest reports World Bank (WB) concluded Turkey might deserve $30 million in bird flu aid. As said by Jurgen Voegele, Bank's East...Battery power from viruses in the pipeline
MIT scientists have developed a technology that uses the construction abilities of tiny viruses to build "nanowire" structures which function as in very thin lithium-ion batteries.// MIT Professors Angela Belcher, Paula Hammond and Yet-Ming Chiang have by simply manipulating a few genes within common laboratory virus strains were able to make the viruses grow and self-assemble into a...Effective Vaccine for Leishmaniasis in the Pipeline
Leishmaniasis is a parasitic disease that kills about 60,000 people annually. It spreads by the bite of infected female sand flies. // Visceral leishmaniasis infects about 500,000 people annually mainly in India, Bangladesh, Nepal, Sudan and Brazil. The most common drugs to treat leishmaniasis have serious side effects and are expensive. Symptoms of visceral leishmaniasis include fever, w...Home Test Kit for AIDS in the Pipeline
OraQuick is a home based test kit to detect AIDS. It is waiting for the FDA to give it an approval to be sold in the market. // The Nasdaq-listed company already sells the kit to hospitals and public health clinics. OraSure's chief executive, Doug Michels, thinks that this product would become an important weapon to fight against HIV. It is almost 25 years since the first AIDS diagnosis w...Thomson CenterWatch Pipeline Intelligence
Description:Keep up with the latest in scientific clinical trial activity and drug development using market intelligence and knowledge resources from CenterWatch. This highly valuable resource has 4 components to help you monitor and stay abreast of medical breakthroughs on the frontiers of medicine: Drugs in Clinical Trials, Clinical Trial Results, Newly Approved Drugs, Clinical Trials Listing Service...Phase I Results for ImClone Pipeline Anti-IGF-1R Monoclonal Antibody IMC-A12 Presented at ASCO
NEW YORK--(BUSINESS WIRE)--Jun 5, 2007 - First-in-human results forIMC-A12, a monoclonal antibody developed by ImClone SystemsIncorporated (NASDAQ: IMCL) and targeted to IGF-1R (insulin-likegrowth factor type 1 receptor), were presented at the annualmeeting of the American Society of Clinical Oncology in Chicago.The IGF-IR is expressed on the cell surface of must human cancersand transmits...Clinical Data on Eisai's Oncology Pipeline to be Presented at ASCO Annual Meeting
Diversity of Abstracts Reflects Continued Growth of Eisai'sCommitment to Oncology WOODCLIFF LAKE, N.J., May 31, 2007 /PRNewswire/ -- Eisaiannounced today that several abstracts covering clinical data abouttheir oncology pipeline compounds have been accepted forpresentation at the American Society of Clinical Oncology (ASCO)annual meeting. ASCO takes place in Chicago from June 1-5,2007.</...MedImmune Highlights Advances in Inflammatory Disease Pipeline With Series of Data Presentations
Data Include Results from Phase 1 Studies with Monoclonal AntibodyTargeting Interleukin-9 (IL-9); Preclinical Data Provide FurtherRationale for IL-9 Inhibition in Developing Potential AsthmaTherapies GAITHERSBURG, Md., May 24, 2007 /PRNewswire-FirstCall/ --MedImmune, Inc. today announced the presentation of datahighlighting recent progress within the company's inflammatorydisease pipelin...